Liminal BioSciences Inc.

Informe acción DB:PJ2

Capitalización de mercado: €11.8m

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

Liminal BioSciences Dirección

Dirección controles de criterios 2/4

Información clave

Bruce Pritchard

Chief Executive Officer (CEO)

CA$1.1m

Compensación total

Porcentaje del salario del CEO54.8%
Permanencia del CEO2.5yrs
Participación del CEO0.04%
Permanencia media de la dirección2.5yrs
Promedio de permanencia en la Junta Directiva4yrs

Actualizaciones recientes de la dirección

Recent updates

Análisis de compensación del CEO

¿Cómo ha cambiado la remuneración de Bruce Pritchard en comparación con los beneficios de Liminal BioSciences?
FechaCompensación totalSalarioIngresos de la empresa
Dec 31 2022CA$1mCA$618k

-CA$29m

Sep 30 2022n/an/a

-CA$31m

Jun 30 2022n/an/a

-CA$35m

Mar 31 2022n/an/a

-CA$42m

Dec 31 2021CA$1mCA$591k

-CA$44m

Sep 30 2021n/an/a

-CA$48m

Jun 30 2021n/an/a

-CA$49m

Mar 31 2021n/an/a

-CA$35m

Dec 31 2020CA$2mCA$556k

-CA$48m

Sep 30 2020n/an/a

-CA$75m

Jun 30 2020n/an/a

-CA$94m

Mar 31 2020n/an/a

-CA$232m

Dec 31 2019CA$5mCA$563k

-CA$150m

Sep 30 2019n/an/a

-CA$299m

Jun 30 2019n/an/a

-CA$298m

Mar 31 2019n/an/a

-CA$194m

Dec 31 2018CA$1mCA$575k

-CA$197m

Sep 30 2018n/an/a

-CA$131m

Jun 30 2018n/an/a

-CA$118m

Mar 31 2018n/an/a

-CA$115m

Dec 31 2017CA$3mCA$526k

-CA$112m

Sep 30 2017n/an/a

-CA$109m

Jun 30 2017n/an/a

-CA$119m

Mar 31 2017n/an/a

-CA$112m

Dec 31 2016CA$2mCA$531k

-CA$101m

Compensación vs. Mercado: Bruce's total compensation ($USD832.66K) is above average for companies of similar size in the German market ($USD435.93K).

Compensación vs. Ingresos: Bruce's compensation has increased whilst the company is unprofitable.

CEO

Bruce Pritchard (48 yo)

2.5yrs

Permanencia

CA$1,127,987

Compensación

Mr. Bruce Pritchard, BA, CA, FioD, served as Principal Financial Officer at Liminal BioSciences Inc. since September 3, 2021. Mr. Pritchard served as Chief Operating Officer of Small Molecule Therapeutics...

Equipo directivo

NombrePosiciónPermanenciaCompensaciónPropiedad
Bruce Pritchard
Chief Executive Officer2.5yrsCA$1.13m0.043%
CA$ 5.1k
Patrick Sartore
President2.5yrsCA$866.09k0.010%
CA$ 1.2k
Gary Bridger
Interim Chief Scientific Officer & Non-Independent Directorless than a yearCA$428.33ksin datos
Marie Iskra
Corporate Secretary & General Counsel3.7yrsCA$637.35ksin datos
N. Rusaw
Chief Financial Officer1.2yrssin datossin datos
Shrinal Inamdar
Manager of Investor Relations & Communicationsno datasin datossin datos
Steven Burton
President of Prometic Bioseparations Ltdno dataCA$294.54ksin datos

2.5yrs

Permanencia media

48yo

Promedio de edad

Equipo directivo experimentado: PJ2's management team is considered experienced (2.5 years average tenure).

Miembros de la Junta

NombrePosiciónPermanenciaCompensaciónPropiedad
Gary Bridger
Interim Chief Scientific Officer & Non-Independent Director4yrsCA$428.33ksin datos
Aleksander Krstajic
Independent Chair of the Board2.7yrsCA$178.00ksin datos
Simon Best
Lead Independent Director9yrsCA$167.58k0.069%
CA$ 8.2k
Eugene Siklos
Non-Independent Director2.7yrssin datossin datos
Benny Soffer
Board Observer4.1yrssin datossin datos
Neil Klompas
Independent Director4yrsCA$132.23ksin datos
Timothy Wach
Independent Director4yrsCA$120.67k0.029%
CA$ 3.4k

4.0yrs

Permanencia media

58yo

Promedio de edad

Junta con experiencia: PJ2's board of directors are considered experienced (4 years average tenure).